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Baculovirus infection results in the induction of membrane structures within the nucleoplasm of the host cells. The source of
these membranes is unclear; however, using the normal dynamics of cellular membranes and the nuclear envelope as a model,
it is possible that the cell cycle might play a role in the regulation of formation of these intranuclear membranes. Therefore, one
goal of this study was to investigate the effect of baculovirus infection on the cell cycle of Sf9 host cells. Since few data are
available on the cell cycle of insect cells, the first task was to define Sf9 cell cycle kinetics. The cell cycle phase distribution of Sf9
cells grown in suspension culture was determined to be evenly distributed (29% of the cells in G1, 33% in S, and 36% in G2/M
phase), with the duration of G1 and S phases both being about 6 h and the combined duration of G2/M phase being about 8 h. When
Sf9 cells were infected with AcMNPV (Autographa californica nuclear polyhedrosis virus), approximately 84% of the cells were
arrested in G2/M phase by 18–24 h p.i. Concomitant with the viral-induced arrest in G2/M phase, high levels of both cdc2-
associated histone H1 kinase activity and cyclin B protein were detected. By 24 h p.i. cyclin B was no longer detected; however,
cdc2-associated histone H1 kinase activity remained throughout the infection. These data suggested that early in infection, cyclin
B/cdc2 complex may be used to regulate the transition from G2 to M phase, but prolonged arrest may be due to a protein(s)
encoded by AcMNPV. DNA hybridization analysis showed that the maximal rate of viral DNA replication occurred before G2/M
arrest. We noted that viral DNA replication still occurred late in infection, when the majority of the cells were arrested in G2/M
phase. Since cellular DNA replication normally does not occur during G2 or M phase, experiments were designed to determine if
viral DNA replication could occur even when host cell DNA replication was arrested. Sf9 cells were arrested and ‘‘frozen’’ at the
boundary of G1/S phase using 5-fluoro-29deoxyuridine (FdUrd) treatment and then infected with AcMNPV. In the blocked, infected
cells, viral DNA replication was detected; however, cellular DNA remained at steady-state levels. These results suggested that
cellular DNA replication was not necessary for viral DNA replication and show that viral DNA replication was not significantly
inhibited by FdUrd treatment. It was a surprise to detect viral DNA replication when the host cells were ‘‘frozen’’ at G1/S phase.
We wanted to determine if the viral infection was progressing to the stage of progeny virus production. Our data showed that
progeny budded virus (BV) and virus-induced intranuclear microvesicles were produced in the frozen, infected cells; however, the
intranuclear microvesicles had an unusual structure. They were irregular in shape and thickened compared to those observed in
a normal infection. Very few enveloped nucleocapsids were visible in the nucleus of the frozen, infected cells and the occluded-
derived virus envelope proteins, ODV-E66 and ODV-EC27, were not detected by Western blot analyses. Since the cells were
sustained at the boundary of G1 and S phases for the duration of this experiment, the decreased amount of enveloped ODV in the
nucleus could be due to several factors, including decreased levels of proteins expressed from late genes, aberrant microvesicles,
or the necessity of G2/M phasing of the infected cell for efficient production and maturation of intranuclear microvesicles. These
data indicate that AcMNPV infection results in cell cycle arrest in G2/M phase and this arrest may be due to a viral-encoded
protein(s) that has cdc2-associated kinase activity. We note that progeny BV are produced even when infected cells are arrested
at the border of G1 and S phases by drug treatment (FdUrd), indicating that arrest in G2/M may not be required for the maturation
of BV. Intranuclear microvesicles are also produced in FdUrd-arrested cells; however, they have an unusual appearance and it may
be that the G2/M arrest is important for optimal maturation and assembly of ODV. © 1998 Academic Press
INTRODUCTION
Studies of the events occurring during baculovirus
infection often include infecting cells in vitro using a
known multiplicity of infection and analyzing the tempo-
ral sequence of events of interest. While this strategy
results in a defined time of primary infection, using se-
lected viral structural protein markers we have observed
that detectable levels of the marker protein(s) were not
uniform among the population of infected cells. This is
easily visualized when using fusion proteins containing
autofluorescent markers (unpublished data). Our obser-
vations suggest that the temporal progression of bacu-
lovirus infection may not be as uniform in the cell pop-
ulation as previously assumed, and the literature sug-
gests that the phase of the cell in the cell cycle at the
time of infection may play a role in influencing the pro-
gression of baculovirus infection (Brown and Faulkner,
1975; Kioukia et al., 1995). Baculovirus infection results in
two types of viral progeny: Budded virus (BV) matures
early in infection by obtaining its envelope from the
plasma membrane of the host cells; and occlusion-de-
rived virus (ODV), which matures later in infection and
obtains its envelope from an intranuclear source of mem-1 To whom reprint requests should be addressed.
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branes. Since BV is the easiest progeny form to quanti-
tate, most studies evaluating the conditions for maximal
virus titers were performed measuring levels of progeny
BV. The highest levels of BV titers are produced when
cells are infected in logarithmic growth (Volkman and
Summers, 1975; Vaughn, 1976), and TN-368 cells syn-
chronized in S phase are more susceptible to AcMNPV
(Autographa californica nuclear polyhedrosis virus) in-
fection than cells in other phases of the cell cycle (Lynn
and Hink, 1978a). It is likely that the state of health and/or
the phase of the host in the cell cycle has an important
role in influencing the rate of temporal progression and
the amount and form of progeny virus (BV and ODV)
produced during baculovirus infection.
It is difficult to study baculovirus infection relative to
insect cell cycle phases because very little is known of
insect cell cycle kinetics in cultured cells. Lynn and Hink
(1978b) used thymidine block and autoradiographic anal-
ysis to define the cell cycle parameters for TN-368 cells
(G1, 1.0 h; S, 4.5 h; G2, 8.5 h; and M, 0.5 h). Fertig et al.
(1990) demonstrated that FdUrd (5-fluoro-29deoxyuridine)
partially synchronized Sf9 cells at the G1/S boundary and
like Lynn and Hink (1978b) noted that the parameters of
Sf9 cell cycle were significantly different than those ob-
served for mammalian cells.
We are studying the process of viral envelope protein
trafficking, assembly, and maturation of ODV in the cell
nucleus. In particular, we are using several proteins
specific for the ODV envelope as markers to identify the
pathway(s) of protein transport and incorporation into
intranuclear microvesicles and ODV envelope (Brauna-
gel and Summers, 1994; Hong et al., 1994; Braunagel et
al., 1996a,b). Based upon our results we hypothesized
that the inner nuclear membrane (INM) proliferates and
‘‘buds’’ into the nucleus, serving as an intermediate in the
formation of viral-induced intranuclear microvesicles and
ODV envelope (Hong et al., 1997). This hypothesis im-
plies that the nuclear envelope serves as a source for
ODV envelope.
Since viruses are highly efficient at redirecting or em-
ulating specific cellular pathways, it may be that some
aspect of the normal dynamics of the nuclear envelope
which occur during the cell cycle may be affected by
baculovirus infection. In an uninfected cell, the nuclear
envelope becomes more fluid and increases in size
twice in the course of the cell cycle: (1) During S phase
the size of the nucleus approximately doubles and (2)
during mitosis, when enlargement of the nucleus is fol-
lowed by nuclear envelope dispersal and reassembly. In
insect cells, membrane structures are observed within
the nucleus during mitosis. During late prophase, the
nuclear envelope of oocytes from the parasitic beetle
Xenos peckii Kirby becomes extremely convoluted and
fenestrated. At this time, vesicular and tubular mem-
brane elements permeate into the nucleoplasm and ap-
pear to arise from the nuclear envelope (Rieder and
Nowogrodzki, 1983). Intranuclear membranes are also
observed in mitotically active tissue of Drosophila mela-
nogaster brain, stem, and follicle cells. In these cells, the
nuclear envelope fenestrates and an intranuclear enve-
lope develops around the mitotic spindles (Stafstrom and
Staehelin, 1984). Studies of the Drosophila INM protein,
otefin, indicate that at least part of the spindle envelope
is derived from the INM (Harel et al., 1989; Pandan et al.,
1990). A similar formation of spindle envelopes is ob-
served in the heteropteran insect, Dysdercus interme-
dius (Motzko and Ruthmann, 1984).
We note that infection by AcMNPV results in enlarge-
ment of the cell, cessation of cell division, and a signif-
icantly enlarged cell nucleus. Areas of nuclear envelope
perturbation are detected (Summers and Arnott, 1969),
but overall, the nuclear envelope remains visually intact
throughout infection. Membrane microvesicles and
membrane fragments appear in the nucleus and are
localized as discrete foci. Thus, using uninfected nuclear
envelope dynamics as a model, it seems plausible to
speculate that baculovirus infection might arrest the host
cell cycle in a phase that is consistent with the appear-
ance of intranuclear membranes (i.e., prophase through
mid metaphase of mitosis). We would also speculate that
the timing of cell cycle arrest would correlate with the
appearance of viral-induced microvesicles and matura-
tion of ODV.
This study was directed by three major observations:
(i) The apparently nonuniform temporal progression of
baculovirus infection that might be dependent upon the
phase of the host cell in the cell cycle at the time of
infection; (ii) the appearance of baculovirus-induced
membrane microvesicles in the nucleoplasm and the
speculation that baculovirus may be arresting the cell
during the early states of mitosis; and (iii) the fact that
AcMNPV infection results in cessation of Sf9 prolifera-
tion, indicating some viral induced cell cycle arrest. Thus
the goals of this study were to (1) establish parameters of
Sf9 cell cycle kinetics and develop the tools and condi-
tions to synchronize insect cells at various cell cycle
stages; (2) determine the effects of AcMNPV infection on
the Sf9 cell cycle; and (3) study events of baculovirus
infection with emphasis on host cell cycle and events
relative to intranuclear microvesicle formation and ODV
maturation.
We demonstrated that AcMNPV infection results in Sf9
cell cycle arrest at G2/M phase. Baculovirus infection
resulted in sustained high levels of cdc2-associated hi-
stone H1 kinase activity even though cyclin B protein
was degraded, suggesting that infected Sf9 cells were
arrested at a stage early in mitosis. An unexpected result
from this study was our observation that viral DNA rep-
lication still occurred after cells were arrested in G2/M
phase and that viral infection and viral DNA replication
occurred in cells that were frozen at G1/S boundary by
5-fluoro-29deoxyuridine (FdUrd) treatment. These data
suggested that viral DNA replication could occur inde-
pendently of the cell cycle phase of the host cell. The
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production of BV and the appearance of intranuclear
microvesicles also occurred in the FdUrd-treated, in-
fected cells (G1/S arrest); however, the microvesicles had
an abnormal appearance and ODV maturation was not
observed. These observations suggested that while bac-
ulovirus-induced G2/M arrest was not required for mat-
uration of BV and may not be essential for the formation
of intranuclear microvesicles, it may still be important for
efficient ODV assembly and maturation.
RESULTS
Sf9 cell cycle kinetics and drug arrest studies
The first goal was to define the in vitro cell cycle
kinetics of suspension cultures of Sf9 cells. Flow cytom-
etry indicated that the cell cycle phase distributions of
Sf9 cells were G1 5 29% 6 2.7; S 5 33% 6 6.5; and
G2/M 5 36% 6 7.0 (Table 1, n 5 8). These data are shown
graphically using the FACS histogram in Fig. 2 (0 h p.i.).
Based on these data and the fact that Sf9 cell doubling
time was 18–20 h, the duration of individual cell cycle
stages was estimated to be about 6–7 h. To confirm this,
drug arrest and release studies were performed. Briefly,
these experiments involved synchronizing Sf9 cells at
various stages in the cell cycle using drug inhibitors,
releasing the cells from the block, and determining the
time necessary for the synchronous population of cells to
enter and proceed through the next cycle stage. Since
systematic studies of the effects of drugs on the Sf9 cell
cycle were not available, we had to first evaluate the
ability of drugs to arrest Sf9 cells at different cycle
stages. Because we intended to study Sf9 cells arrested
in certain phases of the cell cycle combined with bacu-
lovirus infection, the drug block analyses were extended
to included the maximal time of successful cell cycle
arrest while maintaining a viable cell culture. FdUrd,
nocodazole, and mimosine successfully arrested Sf9 cell
cultures (See Fig. 9A for overview of cell cycle and site of
drug block). FdUrd is metabolized in vivo to the mono-
phosphate form and blocks cells at G1/S boundary by
blocking thymidine kinase synthetase and preventing
DNA synthesis (Cohen et al., 1958; Sachsenmaier and
Rusch, 1964). FdUrd was tested at a variety of concen-
trations; 4, 40, and 400 mM (data not shown) and 40 mM
was determined to be the optimal concentration for Sf9
cell arrest. After 12 h of incubation with FdUrd, 99% of the
cells were arrested either in G1 or S phase, which is
consistent with a block occurring at the transition of G1
and S phase (Table 1). FdUrd maintained this block
through 90 h of treatment, with cells remaining 95%
viable; however, cell viability began to significantly de-
crease after this time (data not shown). Nocodazole
blocks cells in mitosis by inhibiting the growth of micro-
tubules and spindle formation (Vasquez et al., 1997;
Wang and Burke, 1995). Nocodazole was tested at con-
centrations between 0.25 and 25.0 mg/ml (data not
shown) and 10 mg/ml was determined to be optimal.
Nocodazole-treated cells began to accumulate in M
phase (G2/M as determined by FACS analysis) by 8 h
posttreatment and by 16 h .80% of the cell population
was arrested in M phase (Table 1). After 18 h of nocoda-
zole treatment, the drug began to lose its effectiveness
(compare 16 and 18 h of drug treatment; Table 1), and the
addition of fresh nocodazole at 18 h did not restore cell
arrest in M (data not shown). Mimosine blocks the cell
cycle at the transition of G1 and S phases (Scarano et al.,
1994; Watson et al., 1991). A 1 mM concentration was
determined to be optimal and treatment resulted in 90%
of the cells being arrested in G1/S phase by 24 h (Table
1). Like nocodazole, mimosine was unable to maintain
the phase block for an extended period of time and after
24 h of treatment, the drug began to lose its effective-
ness.
To estimate the duration of individual cell cycle
phases, Sf9 cells were synchronized in M phase by
nocodazole treatment, released from the block, and at
various times postrelease, cell cycle phase distribution
and amount of pulse-labeled uptake of BrdUrd was de-
termined. Figure 1A shows the relative distribution of the
cell population in each phase of the cell cycle after
TABLE 1
Sf9 Cell Cycle Phase Distribution and Drug-Induced Arrest
Fluorodeoxyuridine (40 mM, G2/S phase) Nocodazole (10 mg/ml, M phase) Mimosine (1 mM, G1/S phase)
Time G1 S G2/M Time G1 S G2/M Time G1 S G2/M
12 33 67 1 4 32 26 42 12 25 57 10
18 50 50 1 8 20 22 53 18 35 50 17
24 24 76 1 10 7 34 59 24 34 62 9
36 50 48 2 12 10 38 52 30 34 50 18
48 48 50 4 16 7 9 84
60 46 59 2 18 10 20 70
72 12 78 4 24 21 11 70
Note. Cell cycle phase distribution of Sf9 cells in logarithmic growth. G1, 29% 6 2.7; S, 33% 6 6.5; G2/M, 36% 6 7.0 (n 5 8). This phase distribution
is shown graphically using a FACS histogram in Fig. 2 (0 h p.i.).
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release from the block. During the first 6 h postrelease,
the number of the cells in G1 phase increased and this
increase correlated with a decrease in the number of the
cells in G2/M phase. After 6 h postrelease, the number of
cells in G1 phase decreased, and cells began to accu-
mulate in S phase. The population of cells in G2 phase
was small and constant. After 12 h postrelease, the cell
population in G2 phase increased, which marked the
beginning of the transition from S to G2 phase. BrdUrd
uptake is a widely used method to determine the begin-
ning of DNA replication and starting at 6 h postrelease,
cells began to incorporate BrdUrd, with maximal incor-
poration occurring at 10 h postrelease. By 12–14 h post-
release, BrdUrd incorporation decreased, indicating that
the cells had passed through S into G2 phase (Fig. 1B).
Drug-induced arrest and release studies were also per-
formed using mimosine and FdUrd treatment (data not
shown). Together these data demonstrate that it takes
Sf9 cells approximately 6 h to pass through G1 to S
phase, 6–7 h to progress through S phase, and 6–7 h to
progress through G2/M phase of the cell cycle.
FACS analyses of AcMNPV-infected Sf9 cells suggest
that viral infection arrests the cell population at G2/M
phase
FACS analyses was performed and gating parameters
were set using those defined by uninfected Sf9 cell
populations. Two sets of input data were not reflected in
the number of counted cells: (i) Particles that were out-
side of the size of the gated parameters. These are
shown as small wedge-shaped areas and are composed
primarily of cell debris. (ii) Cells with .4 N DNA content.
These were noted on the FACS histograms (Fig. 2). Thus
the data are quantitated so the number of cells in G1 1
S 1 G2/M 5 100%. Infected cells began to accumulate in
G2/M phase as early as 12 h p.i. (Table 2). By 18 h p.i., a
significant population of cells were in G2/M phase and
remained there for the duration of infection (Table 2 and
Fig. 2). Original data from two representative experi-
ments are shown in Table 2 (Experiments 1 and 2) and
results from multiple experiments are shown in the Sum-
mary column (Table 2). In all experiments, infection re-
sulted in approximately 84% of the cells arrested in G2/M,
3% in S, and 13% in G1 phase. Some experiments dem-
onstrated a delayed progression to cell cycle arrest [ex-
ample: Table 3, Sf9 (E2), represented in the standard
deviation shown in the Summary column of Table 2];
however, ultimately all infected cell populations showed
a similar percentage of cells arrested at G2/M, S, and G1
phases.
Baculovirus DNA replication can occur without
induction of host (cellular) DNA replication
A graphic presentation of the data in Table 2 and
extended time points are shown in Fig. 2 using DNA
histograms. By 18 h p.i., a subpopulation of cells with
more than 4 N DNA content (.4 N DNA) appeared and
accumulated to high levels by 72 h p.i. We noted that at
times when most of the cells were arrested in G2/M
phase, the number of cells with .4 N DNA continued to
increase (Fig. 2; 24–72 h p.i.). This population of cells
could represent (i) Sf9 cells that had undergone DNA
doubling without proceeding through nuclear division (M
phase; polyploidy); (ii) Sf9 cells that had been stimulated
by the presence of the virus to undergo ‘‘unscheduled’’
cellular DNA replication (S phase), and; (iii) Sf9 cells that
contained increased DNA due to viral DNA replication.
Since FACS analyses does not discriminate among these
possibilities, several other approaches were defined.
First, Sf9 cells were infected with AcMNPV, and quanti-
tative Southern blot analyses was used to determine if
viral infection resulted in an increase in cellular DNA
content. The result of this experiment showed that viral
infection did not result in an increase in cellular DNA
content, but rather that DNA content remained at back-
ground steady-state levels [Fig. 3; Sf9 (E2); Sf9 probe].
The observation that levels of cellular DNA remained
unchanged after infection suggested that the subpopu-
FIG. 1. Cell cycle distribution and the rate of BrUrd uptake of Sf9 cells.
Sf9 cells were synchronized in mitosis by 16 h incubation with nocoda-
zole and released from the block by removal of the drug. At various time
points after release, samples were collected and analyzed using FACS.
(A) The time course and relative cell cycle phase distribution after
release from nocodazole block. (B) BrdUrd uptake analysis. This ex-
periment was performed three times and representative data are
shown.
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lation of cells with .4 N DNA was not due to unsched-
uled cellular DNA replication or increased ploidy. The
subpopulation of cells with .4 N DNA likely represented
cells with 4 N cellular DNA content and increased DNA
due to replicating AcMNPV DNA. To evaluate the dynam-
ics of the levels of viral DNA, total DNA from the infected
cells was hybridized to a viral DNA probe. This data
showed that at approximately 12 h p.i., there was a sharp
increase in viral DNA content, and the amount of viral
DNA continued to increase at later times postinfection,
however, at a reduced rate [Sf9 (E2); AcMNPV probe].
The increase in amount of viral DNA continued through
72 h p.i., suggesting that viral DNA replication was oc-
curring even when the infected cell population was
largely arrested at G2/M phase.
To investigate if viral DNA replication could occur
without host DNA replication, Sf9 cells were ‘‘frozen’’ at
the transition from G1 to S phase using FdUrd treatment
FIG. 2. DNA histograms of uninfected and AcMNPV-infected Sf9 cells. Sf9 cells were infected with AcMNPV and at indicated time points samples
were prepared for FACS analyses. Gated parameters were set for an uninfected cell population such that G1 1 S 1 G2/M 5 100%. Cell number (Y
axis) was plotted against red fluorescence (X axis) and the regions of the histograms that correspond to different cell cycle stages and DNA content
.4 N are indicated. This experiment was performed seven times and representative data are shown.
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and then infected with AcMNPV in this arrested state
[Sf9 (E2 1 FdUrd)]. Baculovirus infection did not stimulate
progression of these cells through the cell cycle, and
they remained arrested at the boundary of G1/S phase
throughout the experiment (Table 3). At various times
postinfection, total DNA was purified from the frozen,
infected cells and Southern blot analyses were per-
formed. Viral DNA replication initiated at a time point
somewhat later than that seen for E2 infection (sometime
between 12 and 24 h p.i.), and the rate of synthesis was
decreased compared to E2 infection [Fig. 3; Sf9 (E2 1
FdUrd); AcMNPV probe]. As controls, uninfected cells
were blocked at the boundary of G1 and S phase (FdUrd
treatment) and cellular DNA content was quantitated. In
these cells, steady-state levels of DNA were maintained,
indicating that, as expected, the FdUrd block was suffi-
cient to stop cellular DNA replication [Fig. 3; Sf9 (FdUrd);
Sf9 probe]. These data indicated that induction of bacu-
lovirus DNA replication occurred in the absence of host
Sf9 DNA synthesis and that viral DNA replication oc-
curred in the presence of FdUrd.
G2/M phase arrest does not seem to be required for
production of progeny budded virus (BV)
Since FdUrd treatment affects the levels of TTP pools,
it was most surprising that viral DNA replication occurred
in the presence of this drug. We wanted to determine if,
in the presence of FdUrd, viral infection was proceeding
to the production of progeny virus. When Sf9 cells were
infected with AcMNPV [Sf9 (E2)], a standard 1.5 to 2.5 log
increase over input BV was produced at 36 and 72 h p.i.,
respectively (Fig. 4). Cells that were frozen and then
infected with AcMNPV [Sf9 (E2 1 FdUrd)] also produced
BV, although at reduced levels (Fig. 4). In these cells, by
72 h p.i. there was a statistically significant 1 log in-
crease in virus titer above input virus [Sf9 (E2) 5 2.5 6
0.3; Sf9 (E2 1 FdUrd) 5 1.2 6 0.2].
The detection of BV progeny in the frozen, infected
cells [Sf9 (E2 1 FdUrd)] suggested that BV structural
proteins and possibly structural proteins of the occluded
form of the virus, ODV, were being produced. To address
the extent of structural protein synthesis, infected cell
lysates were collected from both Sf9 (E2) and Sf9 (E2 1
FdUrd) infected cells, and Western blot analyses per-
formed using antibodies to selected AcMNPV structural
proteins. In this experiment, the Sf9 (E2)-infected cells
demonstrated a delay in G2/M arrest relative to most
experiments (i.e., arrest at 36–48 h p.i. vs 18–24 h p.i.; see
Table 3) and this delay was also reflected in a delay of
the temporal detection of structural proteins (Figs. 5A–
5E; for review of time course detection of structural
proteins see Funk et al., 1997). An example of the delay
TABLE 2
Effect of AcMNPV Infection on Sf9 Cell Cycle
Experiment 1 Experiment 2 Summary a
Time G1 S G2/M Time G1 S G2/M Time G1 S G2/M n
4 34 31 35 4 33 24 43 4 27 6 7.8 40 6 19.3 37 6 16.8 3
8 22 44 34 8 16 57 38 8 20 6 2.8 41 6 5.6 48 6 8.9 6
12 18 16 66 12 18 17 67 12 14 6 4.3 33 6 16.1 56 6 15.8 5
18 14 3 82 18 16 3 82 18 12 6 3.7 9 6 10.6 77 6 10.0 7
24 13 3 83 24 13 6 0.6 11 6 13.8 76 6 10.9 3
a In most experiments arrest was completed between 18 and 24 h p.i. In two experiments arrest was delayed by 12–24 h. The standard deviations
reflect these experiments with delayed arrest.
TABLE 3
Effects of Baculovirus Infection on Cells Frozen at the Transition from G1 to S Phase
Sf9 (E2) Sf9 (E2 1 FdUrd) Sf9 (FdUrd)
Time G1 S G2/M Time G1 S G2/M Time G1 S G2/M
12 23 48 30 12a 34 67 1 12a 26 69 2
24 24 41 39 24 34 60 5 24 24 76 2
36 14 27 59 36 25 75 1 36 50 48 3
48 10 2 83 48 29 69 3 48 48 51 4
60 10 3 83 60 25 74 4 60 46 59 2
72 8 2 88 72 18 70 9 72 12 78 3
Note. In addition to the times noted above, samples were removed at 6, 8, 10, and 14 h p.i. for DNA hybridization analysis as shown in Fig. 3.
a Cells were synchronized with FdUrd for 18 h, released, and infected with virus for 1 h. Time 0 is set at the time of removal of unabsorbed virus
and return to FdUrd.
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of the appearance of structural proteins is demonstrated
in the Western blot analysis of the capsid protein, p39. In
the infection that had a delay in cell cycle arrest, p39 was
not detected until 36 h p.i. (Fig. 5C); however, in infec-
tions where cell cycle arrest occurs between 18 and 24 h
p.i. p39 was easily detected at 18 to 24 h p.i. (Fig. 5D).
Both gp67 and BV/ODV-E26 (-E26) are transcribed from
early gene promoters and are known to be BV envelope
proteins (Blissard and Rohrmann, 1989; Guarino and Sum-
mers, 1988; Beniya et al., 1998). We noted that even though
p39 was reported to be transcribed from a late gene (Thiem
and Miller, 1989; Blissard et al., 1989), if a Western blot
analysis was performed of Sf9 (E2)-infected cell lysates and
the membrane exposed for a longer period of time, p39 was
detected as early as 6 h p.i. (Fig. 5D). Since p39 was not
detected in cell lysates from earlier time points (2 and 4 h
FIG. 3. DNA hybridization analysis. 35S-labeled genomic probes were prepared from Sf9 cells or AcMNPV. The probes (0.5 3 106 cpm/blot) were
hybridized against 2 mg of total DNA prepared from Sf9 (E2); Sf9 (E2 1 FdUrd); or Sf9 (FdUrd) at various times postinfection. Hybridization was detected
and quantitated using a PhosphoImager. The data were normalized by setting the background counts to 1, and the slope of the line represents the
change in the levels of DNA. This experiment was performed two times with similar results. It is worth noting that even though this data set is
representive of an experiment with a ‘‘delayed progression’’ of infection, the overall trend is similar when arrest at G2/M phase occurs by 18–24 h p.i.
(i.e., viral DNA replication occurring after G2/M arrest is reproducable).
FIG. 4. Budded virus titers. After infection, virus was adsorbed for 1 h and removed. The cells were washed and returned to fresh media. A sample
was taken immediately after washing to determine residual input virus. Samples of media were removed at the appropriate time point and BV titer
was determined. Each experimental titer was performed three times and read by two people in a blind study. Each titer value represents the average
of the six individual titer determinations. The mean log increases above residual input virus of the 36 h p.i. titer: Sf9 (E2) 5 1.19; Sf9 (E2 1 FdUrd) 5
0.55; and the 72-h log increase: Sf9 (E2) 5 2.5 6 0.3 and Sf9 (E2 1 FdUrd) 5 1.2 6 0.2.
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p.i.) we conclude that the detectable p39 protein does not
represent residual input virus (data not shown). These data
indicated that there was some detectable p39 protein trans-
lation occurring by 6 h p.i.
In frozen, infected cells [Sf9 (E2 1 FdUrd)], gp67, -E26,
and the major capsid protein, p39, were detected in
decreased amounts and at time points later in infection
when compared to Sf9 (E2) infection (Figs. 5A–5C). In
these same frozen cells, however, selected structural
proteins encoded from AcMNPV late genes [e.g., ODV-
EC27 (Fig. 5E; -EC27) and ODV-E66 (-E66)] were below
detectable levels (data not shown; Braunagel et al.,
1996b; Hong et al., 1994).
The lack of detection of structural proteins specific for
ODV suggested either that ODV maturation may not be
occurring in the frozen, infected cells [Sf9 (E2 1 FdUrd)]
or that the temporal progression of infection had not yet
proceeded to the late phase. The experiments were
stopped at 72 h p.i. because cell viability decreased after
this time point due to FdUrd treatment. Experiments us-
ing cells prepared for immunofluorescent microscopy
confirmed the Western blot analysis that -E66 was not
detected in cells infected in the presence of FdUrd [Sf9
(E2 1 FdUrd); data not shown]. Because -E26 was de-
tected in the frozen, infected cells and is present in the
envelope of both BV and ODV (Beniya et al., 1997), -E26
localization was used as a marker to determine the
extent of microvesicle production and ODV maturation.
BV/ODV-E26 was present in foci within the nucleus in
both Sf9 (E2)- and Sf9 (E2 1 FdUrd)-treated cells (Figs. 6A
and 6B; arrows). Since -E26 locates to microvesicles
during E2 infection, and to virogenic stroma when ex-
pressed at high levels under the control of the polyhedrin
promoter (Beniya et al., 1998), this level of resolution
could not adequately resolve the intranuclear location of
-E26. IEM revealed that -E26 was present in intranuclear
microvesicles produced in Sf9 (E2 1 FdUrd)-infected
cells (Figs. 7C–7G; arrows). However, the microvesicles
produced in frozen, infected cells [Sf9 (E2 1 FdUrd)] had
a different structural appearance compared to Sf9 (E2)
infection. A comparison of the microvesicles produced in
Sf9 (E2)- and Sf9 (E2 1 FdUrd)-infected cells is shown in
Fig. 7. Intranuclear microvesicles visualized in Sf9 (E2)-
infected cells have a distinct appearance, with circular,
well-formed vesicles (Figs. 7A and 7B), while micro-
vesicles produced in Sf9 (E2 1 FdUrd)-infected cells
were not as distinct and appeared thickened, with an
electron-dense coating (Figs. 7C–7G; open arrows). We
also observed that the nuclei of the frozen, infected cells
contained very little enveloped virus. Figure 7D repre-
sents the average amount of enveloped virus seen within
the nuclei of the treated cells. Together these data indi-
cated that while infectious BV was produced in Sf9 (E2 1
FdUrd)-infected cells, ODV envelopment was decreased
and/or delayed.
AcMNPV infection affects the levels of Cdc2-
associated histone H1 kinase activity
FACS analyses indicated that baculovirus infection re-
sults in Sf9 cell cycle arrest at G2/M phase and DNA
hybridization experiments showed that the appearance of a
population of cells with .4 N DNA was due to viral DNA
replication. However, additional evidence was still neces-
sary to confirm and precisely place the point of viral in-
duced arrest, at either G2 or M. To further define the place-
ment of arrest, we used known events that occur in mam-
malian cells during G2 and M phases. The onset of mitosis
in all eukaryotic cells is controlled by a protein complex
containing a serine/threonine protein kinase, cdc2, and
cyclin B (Nurse, 1990). A schematic representation of the
levels of cyclin B protein present throughout the cell cycle
is shown in Fig. 8B. Cyclin B accumulates during middle
and late G2 phase and at the onset of mitosis, it locates into
the nucleus where it forms an active complex with cdc2.
The phosphorylation state of cdc2 is cell cycle regulated,
with dephosphorylation leading to increased kinase activity
during mitosis (Draetta and Beach, 1989). The cdc2/cyclin B
complex-associated protein kinase activity correlates with
the depolymerization of nuclear lamins, allowing for nuclear
envelope dispersal. At approximately mid metaphase, cy-
clin B disassociates from cdc2, associated protein kinase
activity decreases, and cyclin B is rapidly degraded via the
FIG. 5. Western blot analysis and structural protein detection. Cells
were infected with or without FdUrd treatment, and lysates collected at
various times points. All lysates were loaded at 15 mg/well. The p39
Western blot using the Sf9 (E2 1 FdUrd) sample was loaded at 40
mg/well. Antibodies used were gp67, AcV1 (1:1000); BV/ODV-E26, No.
7554 (1:1000); p39, Mab39p10 (1:1000), ODV-EC27, No. 7351 (1:1000).
Antibody binding was visualized using secondary antibody bound to
HRP and chemiluminenesce detection. This experiment was performed
three times and representative data are shown.
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ubiquitin pathway. If cyclin B is not degraded, the cell
remains frozen in mid metaphase with an intact nuclear
envelope (Pines and Hunter, 1989; Draetta and Beach,
1989). We chose to analyze levels of cdc2-associated ki-
nase activity and cyclin B protein levels to confirm G2/M
arrest because: (i) The levels of cyclin B function as marker
of the cell position in the cell cycle and (ii) the continuous
presence of cyclin B/cdc2-associated protein kinase activ-
ity in infected cells might explain G2/M arrest as well as the
intact nature of the infected cell nuclear envelope. As a
control, Sf9 cells were synchronized at G1/S phase using
mimosine (18-h drug incubation), released from the block,
and the transition of the cell population through the cell
cycle was monitored using FACS (Fig. 8A; Sf9 cells). At
defined time points, cell samples were collected, antibod-
ies to cdc2 were used to immunoprecipitate the cdc2/cyclin
B complex, and cdc2-associated histone H1 kinase activity
was assayed. The control experiment showed that cdc2-
associated histone H1 kinase activity increased at 8 h post
drug release, the time when the majority of the cells were
at G2/M phase of the cell cycle, and then decreased as the
cell population progressed into G1 phase [Fig. 8A (Sf9
cells)]. FACS analyses was used to verify the cell cycle
phases at each of the time points (data not shown). In Sf9
(E2)-infected cells, cdc2-associated histone H1 kinase ac-
tivity peaked at approximately at 18 h p.i., the time of G2/M
arrest of the cell population (see Fig. 2 and Table 2). The
enzymatic activity then decreased slightly; however, a sig-
nificant amount of cdc2-associated histone H1 activity re-
mained throughout the infection [Fig. 8A; Sf9(E2)].
Normally the levels of cdc2 remain constant through-
out the cell cycle and this was also true when uninfected
Sf9 cells were analyzed using monoclonal antibodies to
cdc2 and Western blot analysis (data not shown). West-
ern blot analysis of infected cell lysates also showed that
the levels of cdc2 remained relatively constant through-
out infection (Fig. 8C; cdc2). Western blot analysis of an
infected cell population using monoclonal antibody to
cyclin B protein showed that at early times postinfection
(4–8 h p.i.) cyclin B was detected. This amount of protein
likely represents that population of cells that was in
either G2 or M phase at the time of infection. At later time
FIG. 6. Immunofluorescence microscopy and localization of BV/ODV-E26. (A and a) Sf9 (E2). (B and b) Sf9 (E2 1 FdUrd). Cells were removed, fixed,
permeabilized, and bound to anti-BV/ODV-E26. Secondary antibody bound to FITC was used to detect primary label and DAPI labeling was performed
to clearly distinguish the nucleus. At 72 h p.i. Sf9 (E2)-infected cells contained many occlusions and BV/ODV-E26 located within the nucleus (arrows).
In Sf9 (E2 1 FdUrd)-infected cells, very few cells contained occlusions, and BV/ODV-E26 also located to foci within the nucleus (arrows).
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FIG. 7. Immunoelectron microscopy and immunogold localization of BV/ODV-E26. (A and B) Sf9 (E2)-infected cells at 48 h p.i. (B) Labeled with BV/ODV-E26
antisera (1:1000, 4°C, 14 h) and 25 nM gold-conjugated secondary antibody. (C–G) Sf9 (E2 1 FdUrd)-infected Sf9 cells. Thickened and unusual morphology
of microvesicles are denoted by open arrows. (C) Preimmune BV/ODV-E26 antisera control showing minimal background reactivity. (D–G) Labeled with
BV/ODV-E26 antisera and 25 nM gold-conjugated secondary antibody. Location of -E26 is noted by arrows. Size bars equal 1 mm.
points (10–12 h p.i.) cyclin B levels dropped significantly,
indicating that at these times postinfection, the majority
of the cell population had proceeded to G1 and S phases.
At 14–18 h p.i. cyclin B levels increased. These data
indicated that by this time, the infected cell population
was primarily in G2 or M phase. The temporal appear-
ance of cyclin B correlates well with the detection of
cdc2-associated protein kinase activity (Fig. 8A). Most
revealing, however, is the significant decrease of cyclin B
protein after 24 h p.i. These data strongly suggest that
the cells were attempting to progress through mitosis. As
cyclin B is degraded, cdc2-associated histone H1 kinase
activity normally ceases. However, during AcMNPV in-
fection, the cdc2-associated histone H1 kinase activity
remained even after cyclin B levels were no longer de-
tectable and the kinase activity was still present through
60 h p.i. (Fig. 8A). Together these data suggested that
early in infection a cellular cdc2–cyclin B complex may
be involved in the regulation of the cell progression from
to G2 to M phase, but that prolonged arrest occurred in
M phase, which might be due to a baculovirus-encoded
regulatory protein.
DISCUSSION
The cell cycle phase distribution of Sf9 cells in sus-
pension culture and logarithmic growth were almost
equally distributed in each phase: 29% of the cells in G1;
33% in S; and 36% in G2/M phase (Table 1 and Fig. 9B)
and the duration of individual cell cycle phases was also
approximately equal: G1, 6 h; S, 6–7 h; and G2/M, 6–7 h.
These data are consistent with an average doubling time
of 18 h for Sf9 cells in suspension culture. Unlike previ-
ous studies with other insect cell lines (Fertig et al.,
1990), FACS analysis did not show an increased ploidy in
a healthy culture of Sf9 cells. The cell cycle phase dis-
tributions of Sf9 and TN-368 cells (Lynn and Hink, 1978b)
are different when compared to the cell phase distribu-
tion of many mammalian cells. Chinese hamster lung
fibroblasts (V79) show a decreased time in G2 and have
a phase distribution of 40% of the cells in G1, 46% in S,
and 12% in G2/M phase (Fertig et al., 1990). Additionally,
when mammalian cells are depleted of growth factors,
they exit the cell cycle from G1 phase with a 2 N DNA
content (Bolton, 1994; and Ohtsubo, 1995). Fertig et al.
(1990) showed that Sf9 and Mamestra brassicae
(IZDMb0503) exit the cell cycle from G2 phase and con-
tain a 4 N DNA content at G0. In agreement with Fertig et
al. (1990), we analyzed Sf9 cells after removal from
freezer stock and prior to logarithmic phase growth and
also found that cells in G0 phase contained a 4 N content
of DNA (data not shown). We also noted that unlike
mammalian cells, cells removed from freezer stock re-
quire a longer time to generate an asynchronous culture
than mammalian cells and that asynchrony is achieved
more rapidly when cells are maintained in suspension
culture than T-flasks (data not shown).
FACS analysis indicated that AcMNPV infection ar-
rested the cell population in G2/M phase (Table 2). The
accumulation of the cells in G2/M phase might also be a
result of cells dying in S and G1 phases. However, since
the viability of the cells at 48 h p.i. was '96%, we
conclude that the G2/M phasing was the result of spe-
cific AcMNPV-induced cell cycle arrest. In every experi-
ment, cell populations were eventually arrested, with
approximate cell cycle phase distributions of 84% of the
cells in G2/M; 3% in S; and 13% in G1 phase. The popu-
lation of cells outside of G2/M could represent cells
arrested at the transition of G1 and S phases. In most
experiments, the arrest was complete between 18 and
FIG. 8. (A) Baculovirus-induced histone H1 kinase activity. Control
Sf9 cells were blocked with mimosine, released from the drug block,
and at various times points postrelease antibody to cdc2 was used to
immunoprecipitate the cdc2 complex and the cdc2-associated histone
H1 kinase activity was assayed (Sf9 cells). Time course samples and
cdc2-immunoprecipitated samples were collected from Sf9 (E2)-in-
fected cells and cdc2-associated histone H1 kinase activity was deter-
mined [Sf9 (E2)]. (B) Cyclin B protein levels. Representative levels of
cyclin B protein throughout the cell cycle are shown. Cyclin B accu-
mulates during G2 phase and in mid metaphase is rapidly degraded.
(C) Cyclin B and cdc2 protein levels during AcMNPV infection. Samples
were collected from Sf9 (E2)-infected cells, 50 mg protein was loaded
onto a 12.5% SDS–PAGE gel, and cyclin B and cdc2 proteins were
detected using Western blot techniques and appropriate monoclonal
antibodies.
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24 h p.i.; however, in some experiments, a delay of cell
cycle arrest (up to 24 h) was observed. In experiments
that showed a delayed cell cycle arrest, the temporal
appearance of structural proteins of the virus was also
delayed (Fig. 5). There is an apparent correlation be-
tween the timing of G2/M arrest, temporal appearance of
structural proteins, and appearance of viral occlusions;
i.e., if arrest is delayed, the temporal progression of the
infection is delayed accordingly. We have no explanation
for the delay of G2/M arrest in some experiments, since
every effort was made to be consistent in conditions for
maintenance of the cells and infection.
Figures 9C and 9E summarize the events of AcM-
NPV infection before and after G2/M arrest. Figure 9E
is an summary overview of an idealized infection. In
the majority of experiments, arrest occurred between
18 and 24 h p.i. Even when viral-induced arrest was
delayed it seemed that early events were prolonged;
however, the events shown after G2/M arrest remained
the same. Consistent with previous studies our results
FIG. 9. Summary overview of temporal events occurring after AcMNPV infection. (A) Site of drug-induced cell cycle arrest. (B) Cell cycle phase
distribution of Sf9 cells. (C) Events that occur after baculovirus-induced arrest in G2/M phase. (D) Events that occur in Sf9 (E2 1 FdUrd)-infected cells.
(E) Overview of temporal sequence of events occurring during an idealized infection by AcMNPV (Fig. 9E, the curve for ‘‘Production of budded virus,’’
was adapted from Volkman et al., 1976).
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showed that the maximal rate of viral DNA replication
occurred around 12 h p.i. (Tjia et al., 1979; and review;
Lu et al., 1997), before the cells were arrested at G2/M
phase (Fig. 9E), and that amounts of cellular DNA
remained at steady-state levels in virus-infected cells.
After the cells were arrested at G2/M phase, viral DNA
replication still occurred, but at a slower rate (Figs. 3
and 9E). Either cells outside of G2/M phase were
responsible for the late replication of viral DNA or viral
infection and gene expression provide the necessary
factors for DNA replication during times in the cell
cycle when cellular DNA replication does not occur.
This speculation is further supported by the observa-
tion that in frozen, infected cells [Sf9 (E2 1 FdUrd)],
viral DNA replication occurred and initiated at a time
point similar to that of Sf9 (E2), while an increase in
cellular DNA content was not detected (Figs. 3 and
9D). These data also demonstrated that viral DNA
replication occurred in the presence of FdUrd.2
Virus-encoded products can initiate events outside of
the expected host cell cycle phase. Two herpesviruses,
Herpesvirus saimiri and Karposi’s sarcoma-associated
herpesvirus code for a homologue to cyclin D. The virus-
encoded cyclins can associate with cdk6 and catalyze in
vitro phosphorylation of both histone H1 and pRB (God-
den-Kent et al., 1997). This is in contrast to the host cell
cyclin D–cdk6 complex, which has a substrate specificity
confined to pRB. Additionally, both viral cyclin–cdk6 com-
plexes may be resistant to inhibition by the CDK inhibi-
tors p16Ink-4a, p21Cip1, and p27Kip1, and expression of viral
cyclin prevents G1 arrest imposed by each inhibitor and
stimulates cell cycle progression in quiescent fibroblasts
(Chang et al., 1996; Swanton et al., 1997). These obser-
vations indicate that the herpesvirus cyclin–kinase com-
plexes are able to mediate progression of events through
checkpoints in the cell cycle. Human immunodeficiency
virus type 1 contains a structural protein, vpr, which
functions to arrest and stop proliferation of the host cell
(Mahalingam et al., 1997). Thus two models, the product
of a viral gene that functions to mimic cell cycle regula-
tors or presentation of such proteins immediately upon
infection via a viral structural protein, suggest that some
viruses have the capacity to control, regulate, and/or
‘‘override’’ cell cycle-regulated events. The results from
this study showed that baculovirus DNA replication still
occurred when the cell population was arrested at G2/M
and when the host cell was ‘‘frozen’’ at the transition state
between G1 and S. These results allow speculation that
AcMNPV also encodes proteins capable of overriding
cell cycle-regulated events and this protein(s) may be
playing a vital role in maintaining baculovirus DNA rep-
lication late in the infection process.
Even in the presence of FdUrd, progeny BV and the BV
structural proteins gp67, -E26, and p39 were detected
[Sf9 (E2 1 FdUrd)]. Both gp67 and -E26 are translated
from early and late promoters, while p39 translation is
reported to initiate only from late viral motifs (Blissard et
al., 1989; Thiem and Miller, 1989). However, we show in
Sf9 (E2)-infected cells that p39 was detected (at low
levels) early in infection (Fig. 5). The promoter region of
p39 contains a CAGT motif (nt -317) which is two nucle-
otides downstream of a recognized TAAG sequence. Is it
possible that this promoter is utilized early in infection,
but transcripts are not detected because they are
present at low levels? Our results suggest that this is
possible. Thus the results of the frozen, infected cells
may indicate that under these conditions, early but not
late genes were expressed. The structural proteins of
ODV envelope that are produced from late genes, -E66
and -EC27 (Fig. 5), were not detected, and electron mi-
croscopy suggested that while nucleocapsids were pro-
duced, enveloped ODV was present in very low amounts.
The decreased amount of enveloped ODV in the nucleus
could be due to several factors, including decreased
levels of proteins expressed from late genes, aberrant
microvesicles, or a requirement of G2/M phasing of the
infected cell for the efficient production and maturation of
intranuclear membranes.
The research of this laboratory is focused on identify-
ing the biochemical pathways of protein trafficking, as-
sembly, and maturation of ODV, with emphasis on the
biochemistry of formation of viral-induced membrane mi-
crovesicles within the nucleoplasm of the infected cell. In
the frozen, infected cells [Sf9 (E2 1 FdUrd)], intranuclear
microvesicles were produced and -E26 was incorporated
into them, indicating that nuclear trafficking of -E26 was
not affected by FdUrd treatment. The observed structure
of the intranuclear microvesicles was unusual compared
to that of the wild type: They were thicker, less uniform in
size, and coated with an electron-dense material. At
present, we cannot explain the differences in the physi-
cal appearance of the microvesicles. It may simply re-
flect the lack of viral structural proteins that would be
present in these structures during a normal infection (i.e.,
-EC27, -E66, and others) or it may be that virus-induced
arrest in G2/M phase was required for efficient matura-
2 After the submission of this paper, Prikhad’ko and Miller (1998)
reported that in transient transfection assays, the IE2 gene product was
sufficient to arrest Sf21 cells. The arrested cells did not undergo
mitosis, had abnormally large nuclei, and contained .4 N DNA content.
The authors indicate that the presence of IE2 arrested the cells in S
phase and suggested that this gene altered the normal control of
cellular DNA replication. Since our data show that baculovirus infection
does not stimulate ‘‘unscheduled’’ cellular DNA replication, we assume
that there must be additional genes that regulate viral vs cellular DNA
replication. Carson et al. (1991) showed that IE2 transcripts are present
immediately after infection yet decrease to low levels by 18 h p.i.; thus
IE2 would be expected to function at time points early in infection.
Together, these data may be further indications that the biphasic nature
of AcMNPV infection is organized to maximize viral DNA replication
and BV maturation early in infection, while later in infection gene
regulation is directed to achieve optimal maturation of the occluded
form of the virus.
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tion. These results indicated, however, that G2/M arrest
may not be required for production of microvesicles.
Additionally, the microvesicles still locate to discrete foci
within the nucleus (Fig. 6), indicating that membrane
trafficking within the nucleus may also not be dependent
upon AcMNPV-induced G2/M phase arrest.
Concomitant with the viral-induced arrest in G2/M
phase, fluctuations in the level of cyclin B protein were
detected (Fig. 8). The additional observation that cdc2-
associated histone H1 kinase activity remained high
even after the cyclin B protein was no longer detected
suggests: (1) AcMNPV-induced cell cycle arrest should
more precisely be placed in M phase; and (2) AcMNPV
may be coding for its own cyclin homologue and this viral
protein or protein complex might be responsible for the
sustained cdc2-associated histone H1 kinase activity
and arrest in M phase.
The results of this study are consistent with the initial
hypothesis that to maximize maturation of ODV, AcMNPV
might be arresting the host cell in a phase of the cell
cycle with increased nuclear membrane fluidity and that
this phase would likely be early in the mitotic cycle. If
further studies support this hypothesis, then the study of
baculovirus-infected cells may reveal important insights
about cellular events that occur at the boundary of G2
and M phases and potentially in the early phases of
mitosis.
MATERIALS AND METHODS
Insect cell lines and virus
Spodoptera frugiperda IPLB-Sf21-AE clonal isolate 9
(Sf9) cells were cultured in suspension at 27°C in
TNMFH medium (Summers and Smith, 1987) supple-
mented with 10% fetal bovine serum (complete media).
All experiments were performed on Sf9 cells in log phase
growth. This was accomplished by seeding cells at 0.5 3
106 cells/ml and allowing the cells to grow for 24 h; thus,
cells were at a density of '1.2–1.5 3 106 cells/ml at the
time of infection and/or drug treatment. The baculovirus
AcMNPV (strain E2) was used and cells were infected at
a multiplicity of infection (m.o.i.) of 20.
Flow cytometry analysis (FACS)
Fluorescence measurements were performed on a
Becton–Dickinson FACS flow cytometer (Mountain View,
CA; School of Medicine, Texas A&M University) as pre-
viously described with some modifications (Belyavskyi et
al., 1994). After collection, cells were washed in phos-
phate-buffered saline (PBS, pH 7.0) and fixed in 70%
EtOH. Prior to analyses, cells were passed through a
23-gauge needle to break up cell clusters and fixed cells
were washed twice in PBS (pH 7.0) and resuspended in
0.5 ml of propidium iodide (50 mg/ml in PBS, 0.1% Triton
X-100, 5 mg/ml RNase) solution for 15 min at 37°C. The
data were gated to eliminate particles that were out of
the size range of Sf9 cells and analyzed using a two-
parameter histogram, plotting cell numbers vs red fluo-
rescence. At least 5 3 104 cells were counted in each
assay. The fraction of the total cell population presented
in each cell cycle phase (G1, S, and G2/M) was obtained
from DNA histograms using ModFit software.
Cell cycle inhibitors and baculovirus infection
Cell cycle inhibition drugs were used to determine the
duration of the cell cycle phases of Sf9 cells (Belyavskyi
et al., 1994). Nocodazole (G2/M; Sigma, St. Louis, MO);
FdUrd (G1/S; Sigma), and mimosine (G1/S; Sigma) were
titrated to determine the minimal concentration and du-
ration of treatment that blocked Sf9 cell cycle. A range of
concentrations for each drug was added to cells in log-
arithmic growth and the cell cycle phase distribution was
determined using FACS.
To study the effects of baculovirus infection on Sf9 cell
cycle, Sf9 cells were infected with AcMNPV for 1 h (0
time point was defined by addition of virus), unabsorbed
virus was removed after 1 h and samples were collected
at various times postinfection. After collection, cells were
washed in PBS (pH 7.0), fixed in 70% EtOH, and stored at
220°C until FACS analysis.
Labeling with BrdUrd
Labeling with BrdUrd was done as previously de-
scribed, with some minor modifications (Belyavskyi et al.,
1996). Briefly, Sf9 cells were synchronized at different cell
cycle stages by 18–24 h incubation in medium containing
the cell cycle inhibiting drug. The cells were washed
twice in PBS and resuspended in fresh TMNFH (com-
plete), and at defined time points after release from the
block, BrdUrd (1 mM stock in PBS, Sigma) was added to
the media (up to 10 mM) and then they were incubated
for 90 min. The cells were collected, washed twice in
PBS, fixed in 70% ethanol, and stored at 220°C. To
enumerate cells which incorporated BrdUrd, DNA was
denatured by incubation in 1 ml 0.1 M HCl with pepsin
(Boehringer Mannheim, 0.4 mg/ml) for 10 min at room
temperature. The acid was neutralized by washing the
cells twice with 0.1 M sodium tetraborate (pH 8.5) and
resuspending them in 50 ml of PBS containing 0.5%
Tween 20 and 1% BSA. Twenty microliters of fluorescein
isothiocyanate-conjugated (FITC) anti-BrdUrd (Becton–
Dickinson) was added and incubated for 30 min at room
temperature. Cells were centrifuged (500 g, 3 min; mi-
crofuge), resuspended in 0.5 ml propidium iodide (50
mg/ml in PBS, 0.1% Triton X-100, 5 mg/ml RNase) for 15
min at 37°C, and analyzed by FACS.
To determine BrdUrd incorporation, bivariant analysis
of DNA/BrdUrd was performed as described previously
(Belyavskyi et al., 1996). Briefly, green fluorescence (FITC
anti-BrdUrd) was collected through a 530/20 nm band-
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pass filter set, and red fluorescence (DNA content from
propidium iodide staining) was collected above 630 nm.
With each flow cytometric analysis a negative control
(cells that were stained with anti-mouse FITC IgG at the
same concentration as anti-FITC BrdUrd) was run to set
the high voltage on the green Photo Multiplier Tube. The
anti-BrdUrd relative fluorescence intensity (RFI) was cal-
culated as the ratio of the modal green fluorescence of
the cells in S phase to cells in G1 phase of the cell cycle,
using RFI 5 100.0198, where 0.0198 is the factor for the
conversion of log to linear fluorescence distribution and
 is the difference in modal log green fluorescence
channel of cells in S and G1 phases of the cell cycle
(Schutte et al., 1987).
AcMNPV infection of G1/S-arrested cells
Sf9 cells were arrested at the G1/S transition by incu-
bation in TMNFH (complete) media containing 40 mM
FdUrd for 18 h. Cell cycle block was confirmed using
FACS. Cells were washed two times in the media without
drug and infected with AcMNPV (m.o.i. 20; time 0 was
defined by addition of virus). After 1 h unabsorbed virus
was removed and cells were resuspended in fresh me-
dia containing FdUrd. At various time points postinfec-
tion, samples were collected and processed for FACS
analysis, DNA purification, virus titer determinations,
Western blot analysis, and IEM fixation and analysis.
DNA purification, radiolabeling of DNA probes, and
quantitative dot blot analysis
Samples of cells (5 3 106) were collected at various
times postinfection and total DNA was extracted using
DNAzol Reagent (Life Technologies, GibcoBRL, Gaithers-
burg, MD) following the manufacturer’s instructions. After
isolation, DNA was resuspended in 0.5 3 TE (pH 6.5) and
quantitated. Genomic DNA was purified from uninfected
cells and BV collected from AcMNPV-infected cells (72 h
p.i.; O’Reilly et al., 1994). It was then labeled using the
technique of random priming and [35S]dATP (Sambrook
et al., 1989). Total DNA (2 mg) was blotted onto a Zeta-
Probe GT membrane and cross-linked to the membrane
using the GS Gene Linker UV Chamber (Bio-Rad) accord-
ing to manufacturer’s instructions. The membranes were
hybridized with either host DNA-specific probe or viral-
specific probe (0.5 3 106 cpm/blot; 65°C, 16 h) and
washed according to standard protocol (Sambrook et al.,
1989). The amount of probe hybridized to the membrane
was quantatited using PhosphoImaginer SF (Molecular
Dynamics).
Protein determination, SDS–PAGE electrophoresis,
and Western blot analysis
Protein concentrations were determined by the
method of Bradford (1976). SDS–PAGE was performed
according to Laemmli (1970; 4% stack, 12.5 or 15% sep-
arating gel). Samples were incubated in 1.5% SDS, 0.5%
b-mercaptoethanol, 25 mM Tris–HCl (pH 6.8), and 7%
glycerol for 15 min at 65°C. Following electrophoresis
the gels were transferred onto Immobilon-P (Millipore,
Bedford, MA). The membranes were blocked with TTBS-
BLOTTO (150 mM NaCl, 10 mM Tris, 1% nonfat dry milk,
0.1% Tween 20, pH 8.0). Antibody was bound overnight
(4°C), blots were washed twice with TTBS, and horse-
radish peroxidase-linked IgG (1:5000) was bound for 1 h
at room temperature. Blots were washed three times
with TTBS, reacted for 1 min with ECL (Amersham, Ar-
lington Heights, IL) chemiluminescence reagent and ex-
posed to X-ray film.
The following primary antibodies were used in West-
ern blot experiments: AcV1 (anti-gp67); No. 7554 (anti-BV/
ODV-E26); Mab39p10 (anti-p39); No. 7351 (anti-ODV-
EC27); cdc2 p34 (17), (anti-cdc2, Santa Cruz Biotechnol-
ogy, Santa Cruz, CA); cyclin B1 (GNS1) (anti-cyclin B,
Santa Cruz).
Budded virus (BV) titer determination
Budded virus titers were determined using the limiting
dilution method described by Summers and Smith (1987).
To assure impartial determinations, each set of titers
was set up in triplicate and coded to be a blind study.
Titers were determined independently by two individuals
and an average was taken of all six resultant titers to
represent one experiment.
Immunofluorescence microscopy (IFM)
Cells were processed for light microscopy using a
modification of previously described procedures (Charl-
ton and Volkman, 1991). Sf9 cells were infected (m.o.i. 20)
and at the appropriate time postinfection, cells were
rinsed with Grace’s media and fixed with 3.7% parafor-
maldehyde in PBS (20 mM phosphate, 140 mM NaCl, pH
7.2) for 10 min at room temperature. Fixative was re-
moved, and cells were washed and permeabilized with
methanol (10 min) and subsequent treatment with 0.5%
Triton-X 100 (10 min), followed by two rinses with PBS.
Cells were incubated in primary antibody (anti-BV/ODV-
E26, No. 7554, 1:1000; and anti-ODV-E66, No. 5297,
1:1000 in normal goat serum 1:20, PBS) for 30 min. Cells
were rinsed twice and secondary antibody (FITC;Sigma,
1:100 in PBS) was added and incubated for 30 min. Cells
were washed and the nucleus was visualized by staining
the cells with DAPI (0.1 mg/ml in PBS). Cells were viewed
and photographed with a Zeiss Axiovert 135 Photomicro-
scope.
Immunoelectron microscopy (IEM)
Samples and ultrathin sections were prepared for
electron microscopy using LR White as described by
Hong et al. (1994). Sections were blocked with TTBS–
BSA (1% BSA, 50 mM Tris–HCl, 150 mM NaCl, 0.05%
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Tween 20, pH 7.4) for 15 min, reacted with primary anti-
body (anti-BV/ODV-E26, No. 7554; 1:1000, 12 h, 4°C), and
washed (TBS, 43 2 min). The bound primary antibody
was detected using gold-conjugated anti-rabbit IgG (25
nm; Electron Microscopy Sciences, Ft. Washington, PA).
The sections were stained with uranyl acetate (Bozzola
and Russell, 1992) and lead citrate (Venable and Cogge-
shall, 1965) and were visualized with a Zeiss 10C trans-
mission electron microscope (Texas A&M University
Electron Microscopy Center).
Cdc2 immunoprecipitation and histone H1 kinase
assay
Cdc2 immunoprecipitation and histone kinase assays
were performed as previously described (Belyavskyi et
al., 1996). Briefly, at indicated times postinfection, Sf9
cells were lysed in RIPA buffer (50 mM Tris, 150 mM
MaCl, 0.5% Triton X-100, 0.5% deoxycholate, pH 7.5) con-
taining protease inhibitors (1 mM PMSF; 10 mg/ml leu-
peptin; 10 mg/ml aprotinin; 2 mg/ml a-macroglobulin; 1
mg/ml pepstatin A; and 1 mM E64) and phosphatase
inhibitors (0.2 mM sodium orthovanadate, 30 mM sodium
pyrophasphate, 50 mM sodium fluoride, and 1 mM
EDTA). A 5-ml aliquot was removed and analyzed for
protein concentration using the technique of Bradford.
Total protein (150 mg) from each sample was dissolved
in 1 ml of RIPA buffer and immunoprecipitated with 7 ml
of antibody to cdc2 (Santa Cruz). Immune complexes
were collected on protein A/G agarose beads. The beads
were washed three times with RIPA buffer and two times
in kinase assay buffer (50 mM Tris, 10 mM MgCl2, 1 mM
DTT, pH 7.5). Kinase reactions were initiated by addition
of 20 ml of a reaction cocktail consisting of kinase assay
buffer prewarmed to 30°C containing 0.1 mg/ml histone
H1 protein (Boehringer-Mannheim) 100 mM ATP, and 50
mCi of [g-32P]ATP (3000 Ci/mmol). Reactions were al-
lowed to proceed for 30 min at 30°C and were termi-
nated by addition of 18 ml of 4X SDS sample buffer (see
SDS–PAGE for buffer formulation). The tubes containing
the reaction were then boiled for 3 min and centrifuged
at 16,000 g for 3 min (microfuge), and the entire sample
was loaded onto a 15% SDS–PAGE gel. Phosphorylated
histone H1 bands were visualized and quantitated using
a PhosphorImager SF (Molecular Dynamics).
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